You just read:

Nektar Therapeutics to Present Clinical Data from Phase 3 SUMMIT-07 Study of NKTR-181, a First-in-Class Investigational Opioid to Treat Chronic Pain, at PAINWeek®

News provided by

Nektar Therapeutics

Aug 30, 2017, 09:00 ET